If you take Mounjaro or are considering treatment, you may have come across headlines about an MHRA warning on pancreatitis. I understand why this might worry you, especially if you are already using the medication. The MHRA describes pancreatitis as uncommon, but the warning highlights why it is important to recognise the symptoms and know when to seek medical help.
Table of Contents
2. What Does The MHRA Pancreatitis Warning Say?
3. How Common Is Pancreatitis With Mounjaro?
4. What Are The Symptoms Of Mounjaro Pancreatitis?
5. When Should I Seek Urgent Medical Help?
6. Who Needs To Take Extra Care For Pancreatic Health?
7. How Can I Take Mounjaro More Safely?
8. What Should I Do Next If I Have Safety Concerns?
9.1. Can Mounjaro cause pancreatitis?
9.2. Does the MHRA warning apply to Wegovy as well?
9.3. Should I stop Mounjaro if I have stomach pain?
9.4. Can I restart Mounjaro after pancreatitis?
9.5. Do I need to tell the hospital staff that I use Mounjaro?
What Is Pancreatitis?
Pancreatitis is inflammation of the pancreas, an organ that produces digestive enzymes and hormones such as insulin. Acute pancreatitis develops suddenly and can range from mild to life-threatening. In severe cases it can cause complications such as dead pancreatic tissue (necrosis), which is why recognising the warning signs early matters.
What Does The MHRA Pancreatitis Warning Say?
The MHRA has strengthened the product information for all UK authorised GLP-1 medicines, including tirzepatide and semaglutide, to highlight the risk of severe acute pancreatitis. Its Drug Safety Update of 29 January 2026 reports include rare cases of necrotising and fatal pancreatitis, which can cause serious damage to the pancreas, including some fatal cases.
Pancreatitis was already a recognised side effect, so this update strengthens the warning about how serious it can become. It applies across the whole class of medicines, rather than to one brand alone. From my perspective as a pharmacist, the key message is to understand the risks without panicking or stopping treatment solely because of the headlines. If you have concerns, speak to your prescriber.
How Common Is Pancreatitis With Mounjaro?
The Mounjaro patient leaflet lists acute pancreatitis as uncommon, meaning it may affect up to 1 in 100 people. Between 2007 and October 2025, the MHRA received 1,296 Yellow Card reports of pancreatitis linked to this class of medicines in the UK. Of these reports, 19 were fatal and 24 involved necrotising pancreatitis.
I would put these figures into context before drawing conclusions. Yellow Card reports record suspected side effects, but they do not prove that a medicine caused each case. They also cannot tell us exactly how likely an individual is to develop pancreatitis while taking Mounjaro. The figures are a reason to take the warning seriously, not a measure of your personal risk.
What Are The Symptoms Of Mounjaro Pancreatitis?
The main warning sign is severe, persistent tummy pain that may spread to your back. You might also experience nausea and vomiting. According to the NHS, the pain can start suddenly.
One difficulty is that some early symptoms can resemble the usual side effects of Mounjaro. The MHRA notes that abdominal pain, nausea and vomiting may be mistaken for common gastrointestinal effects or an infection. These side effects are generally mild or moderate and are more common when your dose increases.
As a pharmacist, I would pay particular attention to pain that is severe, does not settle or keeps returning. Do not assume that persistent pain is simply your body adjusting to the medication. If you are unsure what is causing it, seek medical advice rather than waiting for it to pass.
When Should I Seek Urgent Medical Help?
If you develop severe, persistent abdominal pain, particularly if it spreads to your back or occurs alongside nausea and vomiting, seek urgent medical attention. The Mounjaro patient leaflet advises stopping the medicine and getting urgent medical help if you have severe, persistent stomach pain.
The NHS advises calling 999 or going to A&E if sudden, severe stomach pain occurs alongside any of the following:
- Pain spreading to your back.
- Bloating that does not go away.
- A fast heartbeat or difficulty breathing.
- Blue or bruised skin around your belly button, waist or upper outer thigh.
For severe pain that does not go away or comes with a high temperature, ask for an urgent GP appointment or call NHS 111. Please do not drive yourself to A&E.
When you are seen, always tell the clinician you use Mounjaro, even if it was prescribed privately, because the MHRA notes it may not appear in your records. Bring your pen or packaging. If pancreatitis is confirmed, please do not restart treatment.
Who Needs To Take Extra Care For Pancreatic Health?
If you have had pancreatitis in the past, please tell your prescriber before starting Mounjaro. The MHRA advises caution for people with this history, and the product information states that tirzepatide has not been studied in people who have previously had pancreatitis. As a pharmacist, I always recommend telling your prescriber about your full health history first.
The NHS identifies gallstones and heavy alcohol use as the most common causes of acute pancreatitis. The Mounjaro leaflet also lists gallstones as a common side effect in weight management. If you have a history of gallstones, drink heavily or experience unexplained tummy pain, make sure your clinician knows before treatment begins.
How Can I Take Mounjaro More Safely?
My advice is to read your leaflet, be open with your prescriber and know your warning signs.
- Stay hydrated. If you experience sickness or diarrhoea, maintaining your fluid intake is important. Our guide explains how much water to drink on weight loss medication.
- Review your eating habits. Read our guide to dietary and lifestyle changes on Mounjaro for practical advice during treatment.
- Know when stomach pain needs attention. Our guide on indigestion or a stomach ulcer explains some possible causes of digestive discomfort. However, severe or persistent pain needs urgent medical assessment, not self-diagnosis.
- Check that your pharmacy is registered. Our guide on getting Mounjaro with a prescription explains how to obtain treatment through legitimate channels.
- Report suspected side effects. You can report a suspected reaction to Mounjaro or another medicine through the Yellow Card scheme.
What Should I Do Next If I Have Safety Concerns?
If you are considering Mounjaro or already taking it and have concerns about your treatment, start your consultation with Pharmacy Planet. A UK clinician will review your health information and assess whether Mounjaro is a suitable option for you. If treatment is appropriate, you can take the next step with clinical guidance from our team.
Frequently asked questions
Can Mounjaro cause pancreatitis?
Yes, it can. Acute pancreatitis is a recognised side effect, listed as uncommon, and rare severe cases have been reported. That is why the MHRA strengthened its warning.
Does the MHRA warning apply to Wegovy as well?
Yes. It covers all UK authorised GLP-1 medicines, including semaglutide, tirzepatide, liraglutide and dulaglutide, so it is not specific to Mounjaro.
Should I stop Mounjaro if I have stomach pain?
If the pain is severe and persistent, please stop using it and seek urgent medical help, as the leaflet advises. For milder symptoms, speak to your prescriber or pharmacist promptly.
Can I restart Mounjaro after pancreatitis?
No. The MHRA advises that treatment should not be restarted if pancreatitis is confirmed.
Do I need to tell the hospital staff that I use Mounjaro?
Yes, always, even if you buy it privately. The MHRA notes private prescriptions may not appear in your medical history.
Is mild nausea a sign of pancreatitis?
Not necessarily. Nausea is a very common side effect, mostly mild or moderate. Pancreatitis usually involves severe, persistent pain, but if you are concerned, please speak to a clinician.
This article is for general information and is not medical advice. If you have severe or persistent stomach pain, seek urgent medical help. Mounjaro is a prescription-only medicine and is supplied only after a clinical assessment. Speak to a pharmacist, GP, or prescriber about your own health.
Sources referenced
- MHRA, GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases, Drug Safety Update (29 January 2026)
- NHS, Acute pancreatitis (reviewed 11 March 2026)
- electronic medicines compendium, Mounjaro KwikPen patient information leaflet (last revised August 2026)
- electronic medicines compendium, Mounjaro KwikPen Summary of Product Characteristics (updated 8 September 2026)
- MHRA, Yellow Card scheme


